RedHill Biopharma (RDHL) EBITDA Margin Growth (1y) (2013 - 2023)
RedHill Biopharma (RDHL) EBITDA Margin Growth (1y) (2013 - 2023) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.94 Bn | 42.97 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.08 Bn | 39.43 Bn | 2.15 Bn | -1,647.00 |
| 3 | Zoetis | 31.54 Bn | 29.87 Bn | 1.05 Bn | -368.00 |
| 4 | Takeda Pharmaceutical | 28.60 Bn | 22.80 Bn | 5.10 Bn | -17.00 |
| 5 | United Therapeutics | 22.12 Bn | 19.46 Bn | 683.80 Mn | -341.00 |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | -634.00 |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn | -538.00 |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn | 40.00 |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.96 Bn | - | - |
| 10 | RedHill Biopharma | 2.05 Bn | 2.05 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2023 | 294,295.00 |
| Mar 31, 2023 | -93,490.00 |
| Dec 31, 2022 | 4,962.00 |
| Sep 30, 2022 | -4,002.00 |
| Jun 30, 2022 | -6,581.00 |
| Mar 31, 2022 | 3,868.00 |
| Dec 31, 2021 | -73,327.00 |
| Sep 30, 2021 | 1,147.00 |
| Jun 30, 2021 | 5,593.00 |
| Mar 31, 2021 | -152,314.00 |
| Dec 31, 2020 | -64,804.00 |
| Sep 30, 2020 | -63,360.00 |
| Jun 30, 2020 | -73,226.00 |
| Mar 31, 2020 | 108,097.00 |
| Dec 31, 2019 | 87.00 |
| Sep 30, 2019 | 26,130.00 |
| Jun 30, 2019 | 38,539.00 |
| Mar 31, 2019 | 12,160.00 |
| Dec 31, 2018 | 2,106.00 |
| Sep 30, 2018 | -47,560.00 |